Today: 21 March 2026
Subscribe
Browse Category

NASDAQ:GLW 28 January 2026 - 3 March 2026

Corning stock drops after CFO update, a day after Gorilla Glass Ceramic 3 launch

Corning stock drops after CFO update, a day after Gorilla Glass Ceramic 3 launch

Corning shares dropped 4.3% to $151.04 Tuesday afternoon, reversing part of Monday’s gains after the CFO’s remarks at a Morgan Stanley conference and new product news with Motorola. The decline outpaced the broader market, with the S&P 500 ETF down 0.7%. Investors are reassessing Corning’s near-term prospects after a strong run driven by AI and data-center demand.
3 March 2026
··
Corning stock spikes to fresh highs after Citi lifts target to $170 ahead of OFC

Corning stock spikes to fresh highs after Citi lifts target to $170 ahead of OFC

Corning shares surged 5.3% to $159.57 Wednesday, hitting a record $160.76, as investors bet on its role in AI data-center infrastructure. Citi, Morgan Stanley, and Mizuho all raised price targets ahead of the Optical Fiber Communication conference in March. Corning’s $6 billion supply deal with Meta Platforms remains a key anchor. The next dividend of $0.28 per share goes ex-dividend Feb. 26.
25 February 2026
·
Corning stock (GLW) jumps again as AI data-center cable demand keeps the rally moving

Corning stock (GLW) jumps again as AI data-center cable demand keeps the rally moving

Corning shares climbed nearly 4% Tuesday, hitting a new 52-week high of $152.91 before trading at $150.99 in afternoon action. The stock has surged on heavy volume following a $6 billion supply deal with Meta and rising earnings forecasts. Monday’s close marked a second straight session of gains, with volume more than double the 50-day average. Investors await upcoming conference appearances and the next dividend record date.
24 February 2026
····
Corning stock hits fresh highs after UBS lifts target to $160 as AI-fiber trade rolls on

Corning stock hits fresh highs after UBS lifts target to $160 as AI-fiber trade rolls on

Corning shares jumped 7.3% to $139.51 Friday after UBS upgraded the stock on rising data-center fiber demand, briefly topping $140 for the first time. The move followed a multiyear Meta Platforms contract and comes as hyperscaler capex forecasts surge. Corning’s year-to-date gain neared 60%. Investors will watch for further contract news next week.
21 February 2026
···
Corning stock rises as market slides: what GLW traders are watching next

Corning stock rises as market slides: what GLW traders are watching next

Corning shares rose 1.4% to $111.86 Tuesday, outperforming major U.S. stock ETFs, after forecasting first-quarter sales above Wall Street estimates and announcing a multi-year Meta supply deal. SEC filings show insider sales on Feb. 2, including Eric Musser and Michael Paul O'Day. The stock traded between $109.64 and $117.50 amid volatility. Optical-fiber demand now accounts for nearly 40% of company revenue.
3 February 2026
·
Corning stock slides as traders digest Q1 outlook and Meta’s $6 billion fiber deal

Corning stock slides as traders digest Q1 outlook and Meta’s $6 billion fiber deal

Corning shares fell 3.2% to $106.18 by late morning Wednesday after volatile trading. The company reported fourth-quarter core sales up 14% to $4.41 billion and expects first-quarter core sales of $4.2–$4.3 billion, above estimates. Corning and Meta announced a U.S. data-center supply deal worth up to $6 billion, driving expansion in North Carolina.
28 January 2026
···

Stock Market Today

  • Eli Lilly Valuation: Is $906.70 Share Price Still a Buy After 400% Rise?
    March 21, 2026, 10:11 AM EDT. After soaring 414.3% over five years, Eli Lilly (LLY) closed recently at $906.70. Despite a strong 9.1% return in the past year, the stock faced shorter-term pullbacks up to 16.1% year-to-date. Analysts applying a discounted cash flow (DCF) model estimate an intrinsic value near $1,444.16, suggesting shares may be undervalued by about 37%. Eli Lilly's price-to-earnings ratio stands at 39.24, higher than sector norms, reflecting expectations of continued growth. The multi-faceted valuation approach highlights robust future cash flow projections amid active market sentiment shaped by new therapies and investor interest. While gains have been significant, caution remains amid recent volatility and sector comparisons.
Go toTop